|
|
||||||||
The Annals of Thoracic Surgery, Vol 53, 611-616, Copyright © 1992 by The Society of Thoracic Surgeons
DM Nguyen, DS Mulder and H Shennib
Extracorporeal cardiopulmonary bypass (CPB) has been associated with a wide
variety of immunological derangements, including a transient postoperative
impairment of lymphocyte function. We examined changes in phenotypic and
nonspecific cytotoxicity of peripheral blood mononuclear cells after
extracorporeal CPB. The peripheral blood samples obtained from 10 patients
were subjected to natural killer and cytotoxic T lymphocyte activity assay
before and at intervals after CPB. Phenotypic analysis of peripheral blood
lymphocytes was performed in 5 patients before and immediately after CPB.
We observed a significant increase in peripheral blood CD8+ cells
(cytotoxic/suppressor T lymphocytes) (16.1% +/- 2.5% versus 22.5% +/- 2.1%;
p less than .005) and a decrease in CD4+ cells (helper/inducer T
lymphocytes) (46.1% +/- 3.5% versus 36.1% +/- 3.5%; p less than 0.02)
immediately after extracorporeal circulation. The CD8/CD4 ratio in
peripheral blood was significantly increased immediately after bypass (0.53
versus 0.80; p less than 0.001). No significant changes in percentages of
other leukocyte subsets in peripheral blood were noted. The activity of
cytotoxic T lymphocytes and natural killer cells in peripheral blood was
impaired on postoperative days 1 and 3 but was restored to preoperative
values by removal of mononuclear phagocytes from these cells. The decrease
in natural killer cell and cytotoxic T lymphocyte activity in peripheral
blood may signify a temporary impairment of the effector arm of the
cell-mediated immunity in the post-operative period. The observed changes
in peripheral blood phenotype and function may be involved in early organ
injury and infectious complications after CPB.
ARTICLES
Effect of cardiopulmonary bypass on circulating lymphocyte function
Montreal Lung Transplant Program, Quebec, Canada.
This article has been cited by other articles:
![]() |
T. Sano, S. Morita, M. Masuda, Y. Tomita, T. Nishida, H. Tatewaki, and H. Yasui Cardiopulmonary bypass, steroid administration, and surgical injury synergistically impair memory T cell function and antigen presentation Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 598 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Masuda, Y. Moriyama, R. Toda, S. Shimokawa, Y. Iguro, S.-i. Watanabe, K. Hisatomi, H. Matsumoto, and A. Taira The influence of human T lymphotropic virus type I infection on the outcome of cardiovascular surgery J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 699 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Katoh, K. Tsuchiya, H. Osawa, W. Sato, G. Matsumura, Y. Iida, S. Suzuki, S. Hosaka, S. Yoshii, and Y. Tada Cimetidine reduces impairment of cellular immunity after cardiac operations with cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 312 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawahito, E. Kobayashi, Y. Misawa, H. Adachi, A. Fujimura, T. Ino, and K. Fuse Recovery From Lymphocytopenia and Prognosis After Adult Extracorporeal Membrane Oxygenation Arch Surg, February 1, 1998; 133(2): 216 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hisatomi, A. Kobayashi, Y. Moriyama, S. Shimokawa, H. Toyohira, and A. Taira COMBINED SUPPRESSIVE EFFECT OF CARDIOPULMONARY BYPASS AND AGING ON CELL-MEDIATED IMMUNITY J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 140 - 141. [Full Text] |
||||
![]() |
P. Hornick Cardiopulmonary bypass and the adaptive immune system: perspectives on T cell function Perfusion, May 1, 1996; 11(3): 281 - 290. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |